Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

Something unusual happened on The View on Thursday: the table of hosts found themselves in agreement with Elon Musk.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

CELLEV8 Launches First Post-GLP-1 Gummy Supplement: 'SlimCell™' with Clinically Proven Ingredients to Compliment GLP-1 ...

A slowdown of the digestive tract (gastroparesis) can be a serious side effect, though. Researchers who analyzed the health records of 16 million people revealed that pancreatitis and bowel ...

The digital health company Noom announced Thursday that it is expanding its weight-loss drug offerings to include pills, ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

Medications like Ozempic and Wegovy have made waves for weight loss, but they’re not for everyone. If you’ve been put off by ...

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.